PAVmed (PAVM) Operating Expenses (2015 - 2025)

PAVmed's Operating Expenses history runs 11 years deep, the most recent figure standing at $6.9 million for Q4 2025.

• In Q4 2025, Operating Expenses rose 31.9% year-over-year to $6.9 million; the TTM figure through Dec 2025 stood at $21.9 million (down 37.32% YoY), while the FY2025 annual figure was $21.9 million, down 53.93% from the prior year.
• Operating Expenses was $6.9 million for Q4 2025 at PAVmed, up from $4.8 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $24.7 million in Q4 2022 to a low of $4.7 million in Q2 2025.
• Historically, Operating Expenses has averaged $14.4 million across 5 years, with a median of $15.0 million in 2024.
• The sharpest annual moves came in 2021 and 2024: Operating Expenses soared 164.41% in 2021, then tumbled 70.19% in 2024.
• A 5-year view of Operating Expenses shows it stood at $20.0 million in 2021, then increased by 23.69% to $24.7 million in 2022, then dropped by 29.46% to $17.4 million in 2023, then sank by 70.19% to $5.2 million in 2024, then jumped by 31.9% to $6.9 million in 2025.
• The last three Operating Expenses figures came in at $6.9 million (Q4 2025), $4.8 million (Q3 2025), and $4.7 million (Q2 2025), per Business Quant data.